Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Director Upstream Product Marketing PSMA Late Stage

Telix Pharmaceuticals (AMER)
CompanyTelix Pharmaceuticals (AMER)
CategoryMarketing
LocationUSA- Remote
RemoteRemote
EmploymentNot stated
LevelDirector
SalaryNot stated by the employer
Posted21 May 2026
Last verified12 Aug 2026
SourceEmployer ATS (greenhouse)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.       See Yourself at Telix The Director, Product Marketing – Upstream Late-Stage PSMA is a senior strategic leader responsible for shaping the commercial vision, long-term lifecycle strategy, and value creation for Telix’s late-stage PSMA imaging portfolio—including Illuccix®, Gozellix®, and future lifecycle expansion opportunities. This upstream role serves as the strategic bridge between product development, medical, regional commercial teams, and executive leadership. As Director, you will own the strategic narrative, guide commercial input into late-stage development, and ensure each product is optimally positioned for sustained growth and competitive advantage across all major markets. The Director plays a critical leadership role in influencing pipeline decisions, aligning teams, and driving high-impact commercial strategy that supports Telix’s multi-product PSMA franchise. Key Accountabilities: Late-Stage Commercial Strategy Leadership Lead the development, refinement, and execution of commercial and lifecycle strategies for Illuccix®, Gozellix®, and late-stage PSMA programs. Serve as the primary commercial thought leader guiding market evolution, competitive positioning, and long-range franchise strategy. Working closely with the Global Commercial PSMA team. Build and steward a deep understanding of customer segments—including imaging centers, urology networks, and integrated specialty groups—to shape portfolio and pipeline decisions. Partner with regional leaders and medical counterparts to proactively identify evidence needs and influence data-generation priorities. Business Case Ownership & Forecast Leadership Own the development and executive-level delivery of business cases, TAM/SAM analyses, value assessments, and lifecycle scenario modeling. Collaborate with Commercial Strategy & Operations to pressure-test, align, and update late-stage forecasts and financial assumptions. Anticipate market trends, competitive shifts, and adoption patterns to inform PMC submissions and investment decisions. Convert complex commercial analyses into clear, strategic recommendations for regional leadership teams. Cross-Functional Alignment & Launch Readiness Leadership Act as the senior commercial partner to GDLs, ensuring late-stage development aligns with market needs, differentiation strategy, and launch readiness. Lead cross-functional governance with Medical Affairs, Regulatory, Market Access, and Marketing Operations to ensure regional alignment across lifecycle activities. Oversee commercial contributions to Launch Readiness Reviews (LRRs) and drive post-launch optimization frameworks. Ensure a seamless upstream-to-downstream transition by aligning GTM strategy, messaging, and operational scaling across regions. Market Intelligence & Competitive Strategy Oversee the synthesis of competitive intelligence, including clinical progress, regulatory events, launch timing, messaging, and technology advances. Provide strategic insights that shape brand positioning, lifecycle prioritization, and risk mitigation plans. Monitor policy, reimbursement, and market access shifts to anticipate barriers and opportunities for PSMA imaging adoption. Strategic Program Leadership